FlexiRun Plus40 mg+100 mg

FlexiRun Plus is a combination nutraceutical/dietary supplement marketed to support joint comfort, flexibility, and mobility, mainly in adults with osteoarthritis (OA)-related joint symptoms. It is not an FDA-approved prescription drug, and evidence of benefit varies by study and product formulation.

Evidence-based use classification

• Commonly marketed/guideline-adjunct use: Supportive management of osteoarthritis-related joint pain, stiffness, and reduced joint function, particularly of the knee, used alongside standard medical care.
• Adjunct use: Used together with (not in place of) standard OA management such as NSAIDs/analgesics as prescribed, physiotherapy, exercise, and weight management.
• Evidence caveat: Clinical studies of undenatured type II collagen and of Boswellia serrata extracts individually and in combination show symptomatic improvement in some trials, but results vary by dose, product standardization, and study design; benefit should be presented as evidence-appropriate rather than a definitive disease-modifying claim.
• Not indicated as sole therapy for: Diagnosed inflammatory or autoimmune joint disease (e.g., rheumatoid arthritis) - FlexiRun Plus does not replace prescribed treatment for such conditions.

Each dose/serving of Undenatured Type II Collagen + Boswellia Serrata typically contains: undenatured type II collagen (a proprietary, non-hydrolyzed collagen preparation derived from chicken sternum cartilage, kept in its native/undenatured molecular form) and Boswellia serrata gum resin extract standardized for boswellic acid content (including AKBA - acetyl-11-keto-beta-boswellic acid). Exact strengths and any additional excipients vary by manufacturer and product; refer to the specific product label for precise composition per capsule/tablet.

FlexiRun Plus is a combination joint-health supplement pairing two ingredients with different, complementary proposed mechanisms:

• Undenatured type II collagen: unlike hydrolyzed collagen (which is broken down and used as a raw material for cartilage), undenatured type II collagen is kept in its native molecular form. It is proposed to act through an "oral tolerance" immune mechanism in the gut-associated lymphoid tissue, which may help down-regulate immune-driven inflammatory attack on joint cartilage collagen.
• Boswellia serrata: an Ayurvedic herbal extract (Indian frankincense) whose boswellic acids, particularly AKBA, inhibit the 5-lipoxygenase (5-LOX) enzyme, reducing production of pro-inflammatory leukotrienes.

FlexiRun Plus is marketed as a dietary/nutraceutical supplement for joint comfort and mobility support, most often in adults with osteoarthritis-related symptoms, and is available in Bangladesh through pharmacy and supplement channels in capsule/tablet form.

Nutraceutical / Dietary Supplement - Joint Health Support (Immune-modulating cartilage-support agent [undenatured type II collagen] combined with an herbal anti-inflammatory [Boswellia serrata]). FlexiRun Plus is not classified as a conventional pharmaceutical drug class.

Mechanism of action

Undenatured Type II Collagen + Boswellia Serrata combines two ingredients with distinct proposed mechanisms:

• Undenatured type II collagen: proposed to work via oral tolerance - small, intact (undenatured) amounts of type II collagen presented to gut-associated lymphoid tissue may down-regulate the immune system's inflammatory response directed at native joint cartilage collagen, rather than acting as a structural building block.
• Boswellia serrata: its boswellic acids (notably AKBA) inhibit 5-lipoxygenase (5-LOX), an enzyme in the leukotriene synthesis pathway, thereby reducing pro-inflammatory leukotriene production associated with joint inflammation.

Pharmacokinetics

As Undenatured Type II Collagen + Boswellia Serrata is a dietary supplement rather than a regulated single-molecule drug, formal human pharmacokinetic data (absorption, distribution, metabolism, excretion) are limited compared with conventional medicines. Boswellic acids are known to have relatively low and variable oral bioavailability, which is why standardized, well-formulated extracts are typically used.

FlexiRun Plus is taken by mouth, usually with water. It may be taken with or without food, although taking it with food can reduce the mild stomach upset some users experience, particularly from the Boswellia serrata component. Capsules/tablets should be swallowed whole and not crushed or chewed unless the product is specifically designed for that. For meaningful assessment of benefit, FlexiRun Plus should be taken consistently every day rather than intermittently.

Clinically relevant interaction

• Anticoagulant/antiplatelet drugs (e.g., warfarin, aspirin, clopidogrel): Boswellia serrata has limited data suggesting mild antiplatelet activity. Concurrent use with anticoagulant or antiplatelet medication carries a theoretical additive bleeding risk; patients on such therapy should discuss use of FlexiRun Plus with their prescribing physician before starting.

No other well-verified, clinically significant drug interactions have been firmly established for FlexiRun Plus; however, formal interaction studies for this supplement combination are limited, so any new medication should be discussed with a physician or pharmacist.

FlexiRun Plus is generally well tolerated. Reported side effects are typically mild:

• Mild gastrointestinal upset - nausea, stomach discomfort, bloating, or diarrhea (more often attributed to the Boswellia serrata component).
• Rare hypersensitivity/allergic reactions (e.g., skin rash or itching) in susceptible individuals - see Contraindications.

Report any persistent or severe symptoms to a physician.

Safety data on FlexiRun Plus in pregnancy and lactation are limited. As with most dietary supplements lacking robust human safety data in these populations, FlexiRun Plus should be used only if clearly needed, and only after consulting a physician who can weigh potential benefit against potential risk to the fetus or breastfeeding infant. Routine use without medical guidance during pregnancy or breastfeeding is not recommended.

• Autoimmune joint disease: Because undenatured type II collagen is proposed to act through an immune-modulating (oral tolerance) mechanism, patients with autoimmune diseases affecting the joints (e.g., rheumatoid arthritis) should discuss use of FlexiRun Plus with their treating specialist before starting.
• Bleeding risk: See Interactions for use with anticoagulant/antiplatelet therapy.
• Not a substitute for prescribed treatment: FlexiRun Plus does not replace medically prescribed treatment for diagnosed inflammatory or autoimmune joint disease, and should not be used to delay appropriate medical evaluation of new or worsening joint symptoms.
• Evidence-appropriate expectations: Symptomatic benefit from FlexiRun Plus varies between individuals, studies, and specific product formulations; it should not be regarded as a guaranteed or disease-modifying treatment.
• Time to effect: Response to FlexiRun Plus often takes several weeks of consistent daily use to assess; it is not intended for rapid relief of acute joint pain.
• Keep out of reach of children.

There is no well-established toxic dose profile for FlexiRun Plus as a dietary supplement, and specific overdose data are limited. Taking substantially more than the labeled dose is not advised and may increase the likelihood of gastrointestinal side effects. If a significantly excessive amount of FlexiRun Plus has been ingested, or if severe or concerning symptoms occur, seek immediate medical attention, contact a physician, or contact a poison control/emergency service - do not attempt unsupervised home treatment for suspected overdose.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children.

• Elderly: FlexiRun Plus is commonly used in older adults with osteoarthritis and is generally well tolerated; no specific dose adjustment is established for this population, though caution applies if on anticoagulant/antiplatelet therapy (see Interactions).
• Renal or hepatic impairment: No well-established dosage adjustment has been defined; use with medical guidance.
• Pregnancy and lactation: See Pregnancy and Lactation section.
• Autoimmune joint disease: See Precautions and Warnings.
• Children: See Pediatric Use.

FlexiRun Plus is typically taken continuously on a daily basis for at least 8-12 weeks before symptomatic benefit can be reasonably assessed, since joint supplements generally act gradually rather than providing immediate relief. If benefit is seen and the product is well tolerated, FlexiRun Plus may be continued longer term under periodic medical review; if no meaningful improvement is noted after an adequate trial period, continued use should be reconsidered with a physician.

Joint-health nutraceutical/dietary supplement combination: an immune-modulating cartilage-support agent (undenatured type II collagen) plus an herbal anti-inflammatory, 5-lipoxygenase-inhibiting agent (Boswellia serrata/boswellic acids). Undenatured Type II Collagen + Boswellia Serrata is not classified within a conventional pharmaceutical drug class.

Undenatured Type II Collagen + Boswellia Serrata is proposed to act through two complementary pathways: undenatured type II collagen is thought to trigger a gut-mediated "oral tolerance" immune response that reduces immune-driven inflammatory activity against native joint cartilage collagen, while Boswellia serrata's boswellic acids (notably AKBA) inhibit the 5-lipoxygenase (5-LOX) enzyme, lowering production of pro-inflammatory leukotrienes involved in joint inflammation. Together these mechanisms are proposed to support reduced joint inflammation, pain, and stiffness, and improved joint mobility over time.

Safety and efficacy of FlexiRun Plus have not been established in children and adolescents. As pediatric joint disease requires proper medical diagnosis and management, FlexiRun Plus is not routinely recommended for use in children, and any use in a pediatric patient should only occur under direct medical supervision.